A continuous synthesis method for deuterated heterocyclic compounds and a catalyst fixed bed system

By continuously synthesis of deuterated heterocyclic compounds in the catalyst fixed bed system, the problems of low reaction efficiency and long production cycle in the existing technology are solved, and the rapid and efficient production of deuterated heterocyclic compounds are achieved, thus improving the improvement of the rapid and efficient production of deuterated heterocyclic compounds. Catalyst utilization and product yield.

CN118515627BActive Publication Date: 2024-11-26ANHUI SENRISE TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410977175.1
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-07-22
Publication Date
2024-11-26
Estimated Expiration
2044-07-22

AI Technical Summary

Technical Problem

The existing production technology of deuterated heterocyclic compounds has problems such as low reaction efficiency, cumbersome operation, high risk level and long production cycle, making it difficult to achieve rapid and efficient industrial synthesis.

Method used

The continuous synthesis method and the catalyst fixed bed system are adopted. The continuous synthesis of deuterated heterocyclic compounds is carried out by preheating, reaction and cooling modules in the catalyst fixed bed system. The catalyst fixed bed is fully in contact with the reaction liquid, and combined with high temperature and high pressure With continuous flow technology, the rapid and efficient synthesis of deuterated heterocyclic compounds can be achieved.

Benefits of technology

It improves the production efficiency of deuterated heterocyclic compounds, reduces the production cycle, improves the utilization rate of catalysts, reduces the reaction risk level, and significantly increases the product yield. It is suitable for laboratory trials and industrial production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118515627B_ABST
    Figure CN118515627B_ABST
Patent Text Reader

Abstract

The present invention provides a continuous synthesis method of deuterated heterocyclic compounds and a catalyst fixed bed system, and relates to the technical field of preparation of deuterated heterocyclic compounds. The method comprises the following steps: in an inert gas atmosphere, a heterocyclic compound is mixed with deuterium water to form a clarified solution, and the clarified solution sequentially enters a preheating module, a reaction module, a cooling module, and a back pressure module of a catalyst fixed bed system, and the clarified solution stays in the preheating module and the cooling module of the catalyst fixed bed system for 0.5 to 3 minutes, and stays in the reaction module for 1 to 60 minutes, generating a reaction solution containing deuterated heterocyclic compounds, and the reaction solution is post-processed to obtain deuterated heterocyclic compounds, the preheating module temperature is 100 to 500°C, the reaction module temperature is 100 to 500°C, the reaction module pressure is 1 to 10 MPa, the cooling module temperature is 0 to 30°C, and the back pressure module pressure is 1 to 10 MPa; the reaction module includes a catalyst, and the continuous synthesis of deuterated heterocyclic compounds is realized, the production efficiency is improved, and the production cycle is reduced.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of preparation of deuterated heterocyclic compounds, and in particular to a continuous synthesis method of deuterated heterocyclic compounds and a catalyst fixed bed system. Background Art

[0002] Deuterium, as a stable, non-radioactive hydrogen isotope, has a larger atomic mass. The carbon-deuterium bond formed by combining with carbon is more than 6 times more stable than the carbon-hydrogen bond. Therefore, by replacing hydrogen in specific parts of the drug with deuterium, the body's clearance rate of the drug can be effectively slowed down. Therefore, drugs with deuterated structural modifications can reduce the dosage and reduce the toxic and side effects of drugs without affecting the pharmacological activity, and are widely used in the field of medicine. Deuterated heterocyclic compounds, with the molecular formula: C4D10N2, are a type of nitrogen heterocyclic compound containing deuterium. As a pharmaceutical intermediate molecule, it is widely used in the research and development and preparation of emerging anti-cancer drugs, and plays an important role in the development of the pharmaceutical industry.

[0003] In the existing production technology of deuterated heterocyclic compounds, a one-pot method is generally used in an autoclave. Deuterated water, heterocyclic compounds, and catalysts are added to the autoclave under a nitrogen atmosphere. After sealing, the reactor is heated and stirred at this temperature for dozens of hours. After the reaction is completed, the temperature is lowered to room temperature, the autoclave is turned on for detection, and after reaching the target deuterated degree, the catalyst is filtered out, and then the product is purified by post-treatment. This production technology has a series of problems and hidden dangers: First, the reaction liquid and the catalyst are liquid-solid two-phase, the traditional autoclave reaction has poor mixing effect, the effective contact area with the catalyst is small, the reaction efficiency is low and the amplification effect is significant, which makes it difficult to carry out industrial production; second, the reaction is a high-temperature and high-pressure closed system reaction, and the autoclave reaction sampling is difficult, the operation is cumbersome, and it is difficult to monitor the reaction progress in real time; third, the high-temperature and high-pressure autoclave reaction has a high risk level, and most laboratories or factory workshops do not have the qualifications to enable it; fourth, the reaction takes a long time, and the long production cycle limits its industrial application, making it difficult to quickly and efficiently achieve the synthesis of deuterated heterocyclic compounds. Summary of the invention

[0004] 1. Technical issues to be resolved

[0005] In view of the deficiencies in the prior art, the present invention provides a continuous synthesis method for deuterated heterocyclic compounds and a catalyst fixed bed system, which solves the technical problems existing in the preparation of deuterated heterocyclic compounds by the traditional autoclave method.

[0006] (II) Technical solution

[0007] To achieve the above objectives, the present invention is implemented through the following technical solutions:

[0008] The present invention provides a method for continuously synthesizing deuterated heterocyclic compounds, comprising the following steps:

[0009] Providing a heterocyclic compound, mixing the heterocyclic compound with deuterium water at a certain hydrogen-deuterium molar ratio under an inert gas atmosphere to prepare a clear solution, the clear solution sequentially entering a preheating module, a reaction module, a cooling module, and a back pressure module of a catalyst fixed bed system, and the residence time of the clear solution in the preheating module and the cooling module of the catalyst fixed bed system is 0.5 to 3 minutes, and the residence time in the reaction module is 1 to 60 minutes, generating a reaction solution containing a deuterated heterocyclic compound, and post-treating the reaction solution to obtain a deuterated heterocyclic compound;

[0010] The temperature of the preheating module is set to 100-500°C, the temperature of the reaction module is set to 100-500°C, the pressure of the reaction module is set to 1-10MPa, the temperature of the cooling module is set to 0-30°C, and the pressure of the back pressure module is set to 1-10MPa;

[0011] The reaction module includes a catalyst.

[0012] Preferably, the active ingredient of the catalyst is selected from at least one of ruthenium, ruthenium oxide, palladium, palladium hydroxide, platinum, rhodium, nickel, copper, cobalt and iron; the carrier of the catalyst is selected from at least one of activated carbon, aluminum, aluminum oxide, silicon oxide, titanium oxide, silica gel, pumice and diatomaceous earth.

[0013] Preferably, the ratio of the mass of the catalyst to the mass of the heterocyclic compound raw material is 0.1 to 1:1.

[0014] Preferably, the heterocyclic compound is selected from , , , , , , , , Any one of, the X is independently selected from any one of NH, NCH3, O, S; the Y is independently selected from any one of NH, NCH3, O, S.

[0015] Preferably, the heterocyclic compound includes but is not limited to tetrahydropyrrole, 1-methylpyrrolidine, tetrahydrofuran, tetrahydrothiophene, imidazoline, 1-methylimidazolidine, 1,3-dimethyl-1,3-imidazolidine, 1,3-dithioanal, 1,3-dioxolane, 1,3-oxazolidine, 3-methyloxazolidine, tetrahydrothiazolidine, 3-methylthiazolidine, 1,3-oxathane, piperidine, N-methylpiperidine, tetrahydropyran, cyclopentane sulfide, hexahydropyrimidine, 1-methylhexahydropyrimidine, 1,3-dimethylhexahydropyrimidine, 1,3-dioxane, 1,3-dithiane, 1,3-oxazinane, 3-methyl-1,3-oxazinane, 1,3-thiazinane, 3-methyl- Any one of 1,3-thiazinane, 1,3-oxathiolane, piperazine, N-methylpiperazine, N,N'-dimethylpiperazine, 1,4-dithiane, 1,4-dioxane, morpholine, N-methylmorpholine, thiomorpholine, N-methylthiomorpholine, 1,4-thioxan, heptamethine, 1-methylazepane, thiophene, oxirane, homopiperazine, N-methylhomopiperazine, N,N-dimethylhomopiperazine, 1,4-dioxirane, 1,4-thiazolidine, 1,4-oxazepane, 4-methyl-1,4-oxazepane, tetrahydro-5H-1,4-oxathiophene, 1,4-diazacyclooctane, and 1,5-diazacyclooctane.

[0016] Preferably, the hydrogen-deuterium molar ratio of the heterocyclic compound to deuterated water is 1:2 to 1:20.

[0017] Preferably, the metal content in the catalyst is 0.5-15%.

[0018] Preferably, the catalyst is in the form of a granular or columnar solid.

[0019] Preferably, the post-treatment is purification by distillation, comprising the following steps:

[0020] S1. Compounds with a boiling point lower than that of deuterated water: directly distilling to obtain a pure deuterated compound with a boiling point lower than that of deuterated water in the reaction solution;

[0021] S2. Compounds with a boiling point higher than that of deuterated water: two vacuum distillations: the first vacuum distillation obtains deuterated water in the reaction solution, and the second vacuum distillation obtains a pure deuterated compound with a boiling point higher than that of deuterated water in the reaction solution.

[0022] On the other hand, the present invention provides a catalyst fixed bed system for continuous synthesis of deuterated heterocyclic compounds, comprising a preheating module, a reaction module, a cooling module, and a back pressure module connected in sequence, the reaction module comprising a catalyst, and the active ingredient of the catalyst is selected from at least one of ruthenium, ruthenium oxide, palladium, palladium hydroxide, platinum, rhodium, nickel, copper, cobalt, and iron.

[0023] (III) Beneficial effects

[0024] The present invention provides a continuous synthesis method of deuterated heterocyclic compounds and a catalyst fixed bed system. Compared with the prior art, it has the following beneficial effects:

[0025] The invention discloses a continuous synthesis method of deuterated heterocyclic compounds, comprising a catalyst fixed bed system, wherein the heterocyclic compounds are mixed with deuterated water to form a clear solution, and the clear solution sequentially enters a preheating module with a temperature set at 100-500° C., a reaction module with a temperature set at 100-500° C. and a pressure set at 1-10 MPa, a cooling module with a temperature set at 0-30° C., and a back pressure module with a pressure set at 1-10 MPa of the catalyst fixed bed system. The residence time of the clear solution in the preheating module and the cooling module of the catalyst fixed bed system is 0.5-3 min, and the residence time in the reaction module is 1-60 min, that is, the clear solution reacts in the catalyst fixed bed system to generate a reaction solution containing the deuterated heterocyclic compounds. In addition, the invention realizes continuous production by continuously inputting materials at the front end and continuously outputting qualified products at the terminal outlet through the catalyst fixed bed system. Therefore, the method of the invention couples the traditional high temperature and high pressure reaction with the continuous flow technology, thereby realizing the continuous synthesis of deuterated heterocyclic compounds, improving the production efficiency, and reducing the production cycle.

[0026] In addition, the method of the present invention includes a catalyst fixed bed system, and the catalyst is fully in contact with the reaction liquid in the form of a fixed bed, thereby improving the reaction efficiency, thereby improving the production efficiency and reducing the production cycle. At the same time, the catalyst is fully in contact with the reaction liquid in the form of a fixed bed, which improves the utilization rate of the catalyst, making the utilization rate of the catalyst much greater than that of a traditional kettle reactor.

[0027] Since the method of the present invention includes a catalyst fixed bed system, the catalyst loading amount can be designed according to the feed amount of the reaction, and can be used for both laboratory small-scale research and scale-up production, thereby perfectly connecting laboratory small-scale research and scale-up production.

[0028] The present invention mixes heterocyclic compounds and deuterated water in a catalyst fixed bed system at a hydrogen-deuterium molar ratio of 1:2 to 1:20, and the ratio of the mass of the catalyst to the mass of the heterocyclic compound raw material is 0.1 to 1:1, so that the yield of the prepared deuterated heterocyclic compounds is higher than 85%, which is significantly better than the traditional kettle process. BRIEF DESCRIPTION OF THE DRAWINGS

[0029] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.

[0030] Figure 1 This is a flow chart of the method for continuously synthesizing deuterated heterocyclic compounds in Example 1;

[0031] Among them, 1- clarified solution storage tank, 2- high pressure pump, 3- preheating module, 4- reaction module, 5- cooling module, 6- back pressure module. DETAILED DESCRIPTION

[0032] In order to make the purpose, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention are clearly and completely described. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0033] The embodiments of the present application provide a continuous synthesis method of deuterated heterocyclic compounds and a catalyst fixed bed system, thereby solving the technical problems existing in the preparation of deuterated heterocyclic compounds by the traditional autoclave method.

[0034] The technical solution in the embodiment of the present application is to solve the above technical problems, and the overall idea is as follows:

[0035] The catalyst fixed bed of the present invention can design the loading amount of the catalyst according to the feed amount of the reaction. This feature makes the utilization rate of the catalyst much greater than that of the traditional kettle reactor, and can perfectly connect laboratory pilot research and scale-up production. The present invention couples the traditional high temperature and high pressure reaction with the continuous flow technology. The catalyst is fully in contact with the reaction solution in the form of a fixed bed, which greatly improves the reaction efficiency and greatly improves the utilization rate of the catalyst, thereby greatly reducing the production cost. The method for the rapid and efficient synthesis of deuterated heterocyclic compounds provided by the present invention has the import and export of the entire system at room temperature and pressure, which reduces the risk level of the reaction, the theoretical utilization rate of deuterated water can reach 100%, and the yield of deuterated heterocyclic compounds is higher than 85%, which is significantly better than the traditional kettle process.

[0036] Therefore, the method for continuously synthesizing deuterated heterocyclic compounds of the present invention will be beneficial to process safety, improve product quality, and be green and energy-saving. The catalyst fixed bed system deuteration technology will be an effective way to solve a series of problems of traditional autoclaves.

[0037] In order to better understand the above technical solution, the above technical solution will be described in detail below in conjunction with the accompanying drawings and specific implementation methods. Example 1

[0038] This embodiment provides a continuous synthesis method of deuterated tetrahydropyrrole, comprising the following steps:

[0039] The structural formula of deuterated tetrahydropyrrole:

[0040]

[0041] like Figure 1 , 200g of pyrrole and deuterated water were prepared into a reaction solution according to a molar ratio of H:D of 1:12, and stirred under a nitrogen atmosphere until it was clear. 20g of palladium / alumina catalyst was loaded into the reaction module of the catalyst fixed bed system, and the temperature of the preheating module and the reaction module of the catalyst fixed bed system was set to 180°C, the temperature of the cooling module was set to 20°C, and the pressure of the back pressure module was set to 3MPa.

[0042] The high-pressure pump was turned on to pump the reaction liquid into the catalyst fixed bed system. The residence time of the reaction liquid (clarified solution) in the preheating module and the cooling module in the catalyst fixed bed system was 2 minutes, and the residence time in the reaction module was 30 minutes. The outflowing reaction liquid was subjected to a post-treatment step of distillation to obtain deuterated tetrahydropyrrole with a deuteration degree of 99.3% and a yield of 88.1%. Example 2

[0043] This embodiment provides a continuous synthesis method of deuterated tetrahydrofuran, comprising the following steps:

[0044] The structural formula of deuterated tetrahydrofuran:

[0045]

[0046] 200g of tetrahydrofuran and deuterated water were prepared into a reaction solution according to a molar ratio of H:D of 1:18, and stirred under a nitrogen atmosphere until it was clear. 60g of ruthenium / silicon oxide catalyst was loaded into the reaction module of the catalyst fixed bed system, and the temperature of the preheating module and the reaction module of the catalyst fixed bed system was set to 240°C, the temperature of the cooling module was set to 25°C, and the pressure of the back pressure module was set to 7MPa. The high-pressure pump was turned on to pump the reaction solution into the catalyst fixed bed system. The residence time of the reaction solution in the preheating module and the cooling module in the catalyst fixed bed system was 2min, and the residence time in the reaction module was 50min. The outflowing reaction solution was subjected to a post-distillation treatment step to obtain a deuterated tetrahydrofuran with a deuteration degree of 99.2% and a yield of 87.3%. Example 3

[0047] This embodiment provides a continuous synthesis method of deuterated piperazine, comprising the following steps:

[0048] The structural formula of deuterated piperazine:

[0049]

[0050] 200g piperazine and deuterium water were prepared into a reaction solution according to a molar ratio of H:D of 1:8, and stirred under a nitrogen atmosphere until it was clear. 100g ruthenium oxide / aluminum oxide catalyst was loaded into the reaction module of the catalyst fixed bed system, and the temperature of the preheating module and the reaction module of the catalyst fixed bed system was set to 240°C, the temperature of the cooling module was set to 20°C, and the pressure of the back pressure module was set to 4MPa. The high-pressure pump was turned on to pump the reaction solution into the catalyst fixed bed system. The residence time of the reaction solution in the preheating module and the cooling module in the catalyst fixed bed system was 3min, and the residence time in the reaction module was 60min. The outflowing reaction solution was subjected to a post-distillation treatment step to obtain a deuterated piperazine with a deuteration degree of 99.3% and a yield of 88.2%. Example 4

[0051] This embodiment provides a continuous synthesis method of deuterated morpholine, comprising the following steps:

[0052] The structural formula of deuterated morpholine:

[0053]

[0054] 200g of morpholine and deuterated water were prepared into a reaction solution according to a molar ratio of H:D of 1:10, and stirred under a nitrogen atmosphere until it was clear. 140g of platinum / alumina catalyst was loaded into the reaction module of the catalyst fixed bed system, and the temperature of the preheating module and the reaction module of the catalyst fixed bed system was set to 180°C, the temperature of the cooling module was set to 20°C, and the pressure of the back pressure module was set to 4MPa. The high-pressure pump was turned on to pump the reaction solution into the catalyst fixed bed system. The residence time of the reaction solution in the preheating module and the cooling module in the catalyst fixed bed system was 3min, and the residence time in the reaction module was 40min. The outflowing reaction solution was subjected to a post-distillation treatment step to obtain a deuterated morpholine with a deuteration degree of 99.3% and a yield of 85.2%. Example 5

[0055] This embodiment provides a continuous synthesis method of deuterated hexahydropyridine, comprising the following steps:

[0056] Deuterated hexahydropyridine structure:

[0057]

[0058] 200g of hexahydropyridine and deuterated water were prepared into a reaction solution according to a molar ratio of H:D of 1:15, and stirred under a nitrogen atmosphere until it was clear. 160g of ruthenium / carbon catalyst was loaded into the reaction module of the catalyst fixed bed system, and the temperature of the preheating module and the reaction module of the catalyst fixed bed system was set to 240°C, the temperature of the cooling module was set to 20°C, and the pressure of the back pressure module was set to 5MPa. The high-pressure pump was turned on to pump the reaction solution into the catalyst fixed bed system. The residence time of the reaction solution in the preheating module and the cooling module in the catalyst fixed bed system was 3min, and the residence time in the reaction module was 60min. The outflowing reaction solution was subjected to a post-distillation treatment step, and the deuterated degree of hexahydropyridine was 99.0%, and the yield was 85.3%. Example 6

[0059] This embodiment provides a continuous synthesis method of deuterated heptamethine, comprising the following steps:

[0060] The structural formula of deuterated heptamethine is:

[0061]

[0062] 200g of heptamethine and deuterated water were prepared into a reaction solution according to a molar ratio of H:D of 1:18, and stirred under a nitrogen atmosphere until it was clear. 180g of platinum / carbon catalyst was loaded into the reaction module of the catalyst fixed bed system, and the temperature of the preheating module and the reaction module of the catalyst fixed bed system was set to 300°C, the temperature of the cooling module was set to 20°C, and the pressure of the back pressure module was set to 4MPa. The high-pressure pump was turned on to pump the reaction solution into the catalyst fixed bed system. The residence time of the reaction solution in the preheating module and the cooling module in the catalyst fixed bed system was 3min, and the residence time in the reaction module was 10min. The outflowing reaction solution was subjected to a post-distillation treatment step to obtain deuterated heptamethine with a deuteration degree of 99.1% and a yield of 86.5%. Example 7

[0063] This embodiment provides a continuous synthesis method of deuterated 1,5-diazacyclooctane, comprising the following steps:

[0064] Deuterated 1,5-diazacyclooctane structure:

[0065]

[0066] 200g of 1,5-diazacyclooctane and deuterated water were prepared into a reaction solution according to a molar ratio of H:D of 1:20, and stirred under a nitrogen atmosphere until it was clear. 200g of platinum / carbon catalyst was loaded into the reaction module of the catalyst fixed bed system, and the temperature of the preheating module and the reaction module of the catalyst fixed bed system was set to 320°C, the temperature of the cooling module was set to 20°C, and the pressure of the back pressure module was set to 5MPa. The high-pressure pump was turned on to pump the reaction solution into the catalyst fixed bed system. The residence time of the reaction solution in the preheating module and the cooling module in the catalyst fixed bed system was 3min, and the residence time in the reaction module was 40min. The outflowing reaction solution was subjected to a post-distillation treatment step to obtain a deuterated 1,5-diazacyclooctane with a deuteration degree of 99.0% and a yield of 87.7%.

[0067] Comparative Example 1

[0068] The difference between this comparative example and Example 1 is that 16 g of palladium / alumina catalyst is loaded in the reaction module of the catalyst fixed bed system, and the rest is the same as Example 1. The deuterated tetrahydropyrrole obtained has a deuterated degree of 89.3% and a yield of 75.1%.

[0069] Comparative Example 2

[0070] The difference between this comparative example and Example 1 is that 10 g of palladium / alumina catalyst is loaded in the reaction module of the catalyst fixed bed system, and the rest is the same as Example 1. The deuterated tetrahydropyrrole obtained has a deuterated degree of 88.3% and a yield of 63.1%.

[0071] Comparative Example 3

[0072] The difference between this comparative example and Example 1 is that 220 g of palladium / alumina catalyst is loaded in the reaction module of the catalyst fixed bed system, and the rest is the same as Example 1. The deuterated tetrahydropyrrole obtained has a deuterated degree of 99.2% and a yield of 72.1%.

[0073] Comparative Example 4

[0074] The difference between this comparative example and Example 1 is that 260 g of palladium / alumina catalyst is loaded in the reaction module of the catalyst fixed bed system, and the rest is the same as Example 1. The deuterated tetrahydropyrrole obtained has a deuterated degree of 99.3% and a yield of 65.1%.

[0075] It should be noted that, in this article, relational terms such as first and second, etc. are only used to distinguish one entity or operation from another entity or operation, and do not necessarily require or imply any such actual relationship or order between these entities or operations. Moreover, the terms "include", "comprise" or any other variants thereof are intended to cover non-exclusive inclusion, so that a process, method, article or device including a series of elements includes not only those elements, but also other elements not explicitly listed, or also includes elements inherent to such process, method, article or device. In the absence of further restrictions, the elements defined by the sentence "comprise a ..." do not exclude the existence of other identical elements in the process, method, article or device including the elements.

[0076] The above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit them; although the present invention is described in detail with reference to the above embodiments, it should be understood by those skilled in the art that the technical solutions described in the above embodiments can still be modified, or some of the technical features can be replaced by equivalents; and these modifications or replacements do not make the essence of the corresponding technical solutions deviate from the spirit and scope of the technical solutions of the embodiments of the present invention. Anything not described in detail in the present invention is a well-known technology to those skilled in the art.

Claims

1. A method for continuously synthesizing deuterated heterocyclic compounds, characterized in that: The steps include: Providing a heterocyclic compound, mixing the heterocyclic compound with deuterium water at a certain hydrogen-deuterium molar ratio under an inert gas atmosphere to prepare a clear solution, the clear solution sequentially entering a preheating module, a reaction module, a cooling module, and a back pressure module of a catalyst fixed bed system, and the residence time of the clear solution in the preheating module and the cooling module of the catalyst fixed bed system is 0.5 to 3 minutes, and the residence time in the reaction module is 1 to 60 minutes, generating a reaction solution containing a deuterated heterocyclic compound, and post-treating the reaction solution to obtain a deuterated heterocyclic compound; The temperature of the preheating module is set to 100-500°C, the temperature of the reaction module is set to 100-500°C, the pressure of the reaction module is set to 1-10MPa, the temperature of the cooling module is set to 0-30°C, and the pressure of the back pressure module is set to 1-10MPa; The reaction module includes a catalyst; The ratio of the mass of the catalyst to the mass of the heterocyclic compound raw material is 0.1 to 1:1; The hydrogen-deuterium molar ratio of the heterocyclic compound to deuterated water is 1:2 to 1:20; The active component of the catalyst is selected from palladium; the carrier of the catalyst is selected from alumina; The heterocyclic compound is selected from , , , , , , , , Any one of, the X is independently selected from any one of NH, NCH3, O, S; the Y is independently selected from any one of NH, NCH3, O, S; The metal content in the catalyst is 0.5-15%.

2. The synthesis method according to claim 1, characterized in that The catalyst may be in the form of granules or columnar solids.

3. The synthesis method according to claim 1, characterized in that The post-treatment is purification by distillation, comprising the following steps: S1. Compounds with a boiling point lower than that of deuterated water: directly distilling to obtain a pure deuterated compound with a boiling point lower than that of deuterated water in the reaction solution; S2. Compounds with a boiling point higher than that of deuterated water: two vacuum distillations: the first vacuum distillation obtains deuterated water in the reaction solution, and the second vacuum distillation obtains a pure deuterated compound with a boiling point higher than that of deuterated water in the reaction solution.